Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 157 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

NCT04880850

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Lynn Institute of the Ozarks Little Rock, Arkansas, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • John Muir Physicians Network Concord, California, United States
  • Valley Research Fresno, California, United States
View all 116 locations
View Trial Details
Completed

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before

NCT04460885

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Uni of Alabama at Birmingham Birmingham, Alabama, United States
  • Lakeview Clinical Research, LLC Guntersville, Alabama, United States
  • Lynn Institute of the Ozarks Little Rock, Arkansas, United States
  • Anaheim Clinical Trials Anaheim, California, United States
View all 198 locations
View Trial Details
Completed

Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

NCT04588259

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Anhui Provincial Hospital-Endocrinology Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University-Endocrinology Hefei, Anhui, China
  • Beijing Chao-Yang Hospital, Capital Medical University-Endocrinology Beijing, Beijing Municipality, China
  • The Fifth Medical Center of PLA General Hospital-Endocrinology Beijing, Beijing Municipality, China
View all 40 locations
View Trial Details
Completed

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

NCT05352815

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Pri Med Grp dba/Gil Ctr Fam Gilbert, Arizona, United States
  • Lenzmeier Fam Med CCT Research Glendale, Arizona, United States
  • Phoenician Centers for Research & Innovation PCRI Phoenix, Arizona, United States
  • Medical Investigations, Inc. Little Rock, Arkansas, United States
View all 281 locations
View Trial Details
Completed

Foot-Ankle Exercise and Walking Exercise on Diabetes Mellitus Patients

NCT06518486

Conditions
Cardiovascular Diseases, Diabetes, Diabetes Complications, +19 more
Locations
  • Puskesmas Batang Batang, Central Java, Indonesia
  • Puskesmas Musuk Boyolali, Central Java, Indonesia
  • DPM Alexander Sleman, Special Region of Yogyakarta, Indonesia
  • UPT Puskesmas Lunyuk Sumbawa, West Nusa Tenggara, Indonesia
View Trial Details
Completed

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

NCT05013229

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Lakeview Clinical Research, LLC Guntersville, Alabama, United States
  • Valley Research Fresno, California, United States
  • Scripps Wht Diab Inst La Jolla La Jolla, California, United States
  • Torrance Clin Res Inst, Inc. Lomita, California, United States
View all 182 locations
View Trial Details
Completed

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

NCT05035082

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Stewart Medical Group Alhambra, California, United States
  • FDRC Costa Mesa, California, United States
  • Scripps Whittier Diabetes Inst La Jolla, California, United States
  • Raincross Medical Group Riverside, California, United States
View all 25 locations
View Trial Details

Related conditions